Catalyst Brief

← Calendar

Readoutin 13d

Sanofi Pasteur, a Sanofi Company — PCV21

Phase 3 primary completion: Study of the Safety and Immunogenicity of Catch-up Vaccination With a 21-valent Pneumococcal Conjugate Vaccine (PCV21) in Healthy Infants, Toddlers, Children, and Adolescents.

Date
Dec 2026
Type
Readout
Indication
Pneumococcal Infections

Source ↗Add to calendar

Get told when this date moves

The weekly brief is free. Pro adds reminders 7 days and 1 day before.

More from Sanofi Pasteur, a Sanofi Company

  1. May2027